Search

everythinglearnresearchcommunity

for

Search:↓

Gene differences found in hair follicles linked to male baldness.

Balding and low testosterone increase risk of urinary stones.

Apoptosis may contribute to hair loss in androgenetic alopecia.

Androgens contribute to common male hair loss; more research needed for hair growth medication.

Women with and without hair loss have similar amounts of exogen hairs, so these hairs are not a key factor in hair loss conditions.

ACOD1 deficiency worsens hair loss by causing cell aging and mitochondrial problems, but 4-OI may help.

CD34+ cells decrease in bald areas, while Sox9 stays high, suggesting hair loss in AGA is linked to stem cell issues.

Lower serum irisin levels are linked to androgenetic alopecia but not to insulin resistance.

Hair loss (telogen effluvium) happens before male pattern baldness.

NF-κB levels can help diagnose and assess the severity of androgenetic alopecia.

Male and female pattern hair loss have different molecular pathways, suggesting unique treatment targets for each sex.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

Higher homocysteine levels may inhibit hair growth and are linked to androgenetic alopecia.

Scientists created cell lines from balding patients and found that cells from the front of the scalp are more affected by hormones that cause hair loss than those from the back.

Younger people are at a higher risk for Fibrosing Alopecia in a Pattern Distribution than previously thought, with common symptoms and possible involvement of mast cells in its development.

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

The research provided new insights into the genetic factors contributing to hair loss and skin conditions by analyzing individual cells from the human scalp.

The research found that male pattern hair loss is mostly genetic and involves hair thinning due to hormonal effects and changes in gene expression.

New treatments for hair growth and psoriasis may be possible, and gene differences could affect baldness and the severity of skin conditions.

R-spondin2 may help treat hair loss, gene differences could explain baldness, a peptide's regulation is linked to psoriasis, B-defensin gene copies may affect a skin condition's risk and severity, and potential markers and targets for alopecia areata were identified.

Obesity is linked to more severe hair loss in adult men and to excess hair growth, but its effects on hair conditions are complex and need more research.

Genetically repaired stem cells may treat certain genetic diseases, Th17 cells are key in fighting systemic fungal infections, hair loss in AGA is due to progenitor cell loss, and α-synuclein transfer might contribute to Parkinson's disease progression.

Common hair loss can be diagnosed with a physical exam and sometimes a hair test or skin biopsy, and treated with medication or surgery, with ongoing treatment needed to keep results.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

Fibrosis in the bulge area of hair follicles can cause hair thinning in male pattern baldness, and drugs that inhibit fibrosis might help reverse this.

Osteopontin levels are higher in people with androgenetic alopecia and are linked to metabolic disorders.

Higher myostatin and insulin resistance are linked to androgenetic alopecia.

Higher FABP4 levels may help diagnose androgenetic alopecia early.

Hair loss in Androgenetic Alopecia is not caused by damage to follicular stem cells.